Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 2:58 pm Purchase | 2022-12-31 | 13G | Akero Therapeutics, Inc. AKRO | Avidity Partners Management LP | 3,825,000 8.200% | 720,000 (+23.19%) | Filing History |
| 2023-02-14 2:42 pm Sale | 2022-12-31 | 13G | CYTEIR THERAPEUTICS INC CYTT | Avidity Partners Management LP | 1,795,800 5.100% | -53,738 (-2.91%) | Filing History |
| 2023-02-14 2:26 pm Sale | 2022-12-31 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ | Avidity Partners Management LP | 2,040,000 4.100% | -2,365,000 (-53.69%) | Filing History |
| 2023-02-14 1:58 pm Purchase | 2022-12-31 | 13G | Phathom Pharmaceuticals, Inc. PHAT | Avidity Partners Management LP | 1,900,000 4.600% | 4,000 (+0.21%) | Filing History |
| 2023-02-14 1:38 pm Purchase | 2022-12-31 | 13G | Arvinas, Inc. ARVN | Avidity Partners Management LP | 4,950,000 9.300% | 1,710,162 (+52.79%) | Filing History |
| 2023-02-14 1:10 pm Sale | 2022-12-31 | 13G | IVERIC bio, Inc. ISEE | Avidity Partners Management LP | 838,407 0.600% | -6,116,593 (-87.95%) | Filing History |
| 2023-02-14 12:50 pm Unchanged | 2022-12-31 | 13G | OncoSec Medical Incorporated ONCS | Avidity Partners Management LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2023-02-14 12:41 pm Sale | 2022-12-31 | 13G | Adicet Bio, Inc. ACET | Avidity Partners Management LP | 0 0.000% | -189,625 (Position Closed) | Filing History |
| 2023-02-14 12:19 pm Sale | 2022-12-31 | 13G | Viridian Therapeutics, Inc. VRDN | Avidity Partners Management LP | 0 0.000% | -1,278,261 (Position Closed) | Filing History |
| 2023-02-14 12:02 pm Purchase | 2022-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | Avidity Partners Management LP | 5,150,000 9.000% | 2,127,210 (+70.37%) | Filing History |
| 2023-02-02 3:15 pm Purchase | 2023-01-25 | 13G | Praxis Precision Medicines, Inc. PRAX | Avidity Partners Management LP | 273,333 8.700% | 273,333 (New Position) | Filing History |
| 2022-12-08 10:22 am Purchase | 2022-12-05 | 13G | Karyopharm Therapeutics Inc. KPTI | Avidity Partners Management LP | 756,788 9.900% | 756,788 (New Position) | Filing History |
| 2022-10-27 09:56 am Purchase | 2022-10-26 | 13G | ESSA Pharma Inc. EPIX | Avidity Partners Management LP | 3,750,000 8.500% | 3,750,000 (New Position) | Filing History |
| 2022-09-20 4:35 pm Purchase | 2022-09-16 | 13G | Syros Pharmaceuticals, Inc. SYRS | Avidity Partners Management LP | 2,120,000 9.900% | 2,120,000 (New Position) | Filing History |
| 2022-09-16 10:16 am Purchase | 2022-09-15 | 13G | Akero Therapeutics, Inc. AKRO | Avidity Partners Management LP | 3,105,000 6.900% | 3,105,000 (New Position) | Filing History |
| 2022-06-16 4:38 pm Purchase | 2022-06-15 | 13G | Arvinas, Inc. ARVN | Avidity Partners Management LP | 3,239,838 6.100% | 3,239,838 (New Position) | Filing History |
| 2022-02-14 09:18 am Purchase | 2021-12-31 | 13G | IDEAYA Biosciences, Inc. IDYA | Avidity Partners Management LP | 2,553,000 6.600% | 82,821 (+3.35%) | Filing History |
| 2022-02-11 8:54 pm Purchase | 2021-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | Avidity Partners Management LP | 5,244,019 9.900% | 494,019 (+10.40%) | Filing History |
| 2022-02-11 8:39 pm Purchase | 2021-12-31 | 13G | SCYNEXIS, Inc. SCYX | Avidity Partners Management LP | 2,239,278 9.300% | 259,478 (+13.11%) | Filing History |
| 2022-02-11 8:34 pm Purchase | 2021-12-31 | 13G | OncoSec Medical Incorporated ONCS | Avidity Partners Management LP | 133,864 7.500% | 45,136 (+50.87%) | Filing History |